Attorney general files formal licensing complaint against pharmacy at center of deadly meningitis outbreak

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

INDIANAPOLIS – The Massachusetts-based pharmacy at the center of a deadly outbreak of fungal meningitis now faces a licensing complaint from the office of Indiana’s attorney general.

In November, the Indiana Board of Pharmacy voted for the indefinite suspension of New England Compounding Center’s (NECC) non-resident pharmacy license. Attorney General Greg Zoeller said the board will consider the formal complaint during its Feb. 22 meeting.

The Centers for Disease Control and Prevention said at least seven people have died and identified at least 60 total cases of fungal meningitis in Indiana stemming from steroid injections from NECC. Nationwide, the complaint cites more than 560 cases and nearly 40 deaths across 19 states.

In September, the CDC worked with the Food and Drug Administration to identify NECC as the compounding pharmacy that produced the tainted injections. The center subsequently ceased production and recalled the drugs.

According to the attorney general, NECC is a licensed, non-resident pharmacy whose products were distributed and sold in Indiana. As a result, the pharmacy is legally responsible for the “proper and safe storage and distribution of drugs and devices.”

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.